Dr. Gourisankar Prasad Degala, MD

Dr. Degala practices at West Central Gastroenterology in Clearwater, Florida.

Dr. Degala's NPI, 1245440361, was assigned on May 24, 2007. Dr. Degala graduated from Kempegowda Institute of Medical Science in 2001. Dr. Degala holds Florida license ME113998.

Dr. Degala's primary practice is West Central Gastroenterology, at 508 Jeffords St, Clearwater, FL 33756 in Pinellas County. The practice phone is (727) 347-0005.

Dr. Degala's primary practice is West Central Gastroenterology in Clearwater, Florida. Dr. Degala is also affiliated with Morton Plant Hospital. The medical group on file is Gastro Florida. Dmand AI also links Dr. Degala to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Degala practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Degala's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Degala is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Degala's licenses on file in 3 states: Florida, North Carolina and Michigan.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastrointestinal bleeding, hemorrhoids and intestinal diverticulosis among the conditions Dr. Degala treats.

CMS data shows 856 Medicare services from Dr. Degala across 14 procedure codes in 2024, for 458 Medicare patients. Medicare paid $91,178 for them.

CMS counts 458 Medicare patients who saw Dr. Degala in 2024. The largest group is 65 to 74, with 196 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Degala's median patient age at 67, with 55% women.

In 2024, Dr. Degala wrote 1,704 Medicare Part D claims for 576 patients. 83% of them were for generic drugs. CMS names the drug for 1,514 of them, across 26 drugs with 11 or more claims each, at $1,421,350 in total drug cost. In 2023, CMS named 1,581 claims across 30 drugs.

Dr. Degala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Degala as offering telehealth. CMS counts 197 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Degala, more than 90% of the clinicians it reports for that procedure.

CMS Open Payments shows 605 general payments to Dr. Degala from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Abbvie Inc. paid the most, $3,324.

Dmand AI lists 1 award for Dr. Degala, most recently CMS Stage 1 EHR in 2013.

Dr. Degala graduated from Kempegowda Institute of Medical Science in 2001.

Dr. Degala is in network with 16 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.